Protocol cost analysis.
D000553:Ambulatory Care / Q000191:economics; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000191:economics; D003131:Combined Modality Therapy; D003363:Cost Control / Q000379:methods; D003362:Cost-Benefit Analysis / Q000379:methods; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D015251:Epirubicin; D005251:Fees, Medical; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000191:economics; D006278:Medicare / Q000191:economics; D014750:Vincristine / Q000008:administration & dosage
D015251:Epirubicin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide